Summary
This review article, published in EMBO Reports, explores the hypothesis that the global decline in biodiversity — encompassing environmental, microbial and dietary diversity — contributes to dysregulation of the human immune system and increased prevalence of inflammatory conditions. Drawing on epidemiological and immunological evidence, the authors likely argue that reduced exposure to diverse microorganisms impairs immune tolerance mechanisms. The paper positions biodiversity loss as a public health concern with direct implications for the rising burden of allergic and autoimmune disease.
UK applicability
The findings are broadly applicable to the UK, where rates of allergic and autoimmune disease are high and environmental biodiversity has declined substantially; the paper's arguments may inform UK public health and land management policy linking nature recovery to population health outcomes.
Key measures
Prevalence of inflammatory and allergic diseases; biodiversity indices; microbial diversity metrics; immune biomarkers (inferred)
Outcomes reported
The paper examines the relationship between declining environmental and microbial biodiversity and rising rates of chronic inflammatory and allergic diseases in human populations, likely reporting epidemiological patterns and immunological mechanisms linking reduced biodiversity exposure to dysregulated immune responses.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.